Literature DB >> 34150003

Circular RNA circ_0084927 regulates proliferation, apoptosis, and invasion of breast cancer cells via miR-142-3p/ERC1 pathway.

Guohua Gong1,2, Jikai She1,3, Danni Fu1,3, Dong Zhen1,3, Bin Zhang1,2.   

Abstract

OBJECTIVE: We aimed to investigate the mechanism of circular RNA circ_0084927 in the progression of breast cancer (BC).
METHODS: The levels of circ_0084927, miR-142-3p, and ELKS/RAB6-interacting/CAST family member-1 (ERC1) mRNA in the BC tissues and cells were detected by qRT-PCR. CCK8, colony formation, Transwell, and flow cytometry assays were performed to examine the cell proliferation, colony formation, cell invasion, and apoptosis, respectively, in the BC cells with regulated expressions of circ_0084927, miR-142-3p, and ERC1. RNase R treatment was employed to verify the circular structure of circ_0084927. Nucleocytoplasmic separation experiment, bioinformatics analysis, dual-luciferase reporter assay, and RNA immunoprecipitation were performed to investigate the ceRNA mechanism of circ_0084927.
RESULTS: High levels of circ_0084927 and ERC1 and low levels of miR-142-3p were detected in the BC tissues and cells. Knockdown of circ_0084927 promoted apoptosis and inhibited proliferation, colony formation, and invasion of BC cells (all P<0.05), whereas overexpression of circ_0084927 in the BC cells achieved the opposite effects. miR-142-3p is the target of circ_0084927. Overexpression of miR-142-3p could inhibit BC cell proliferation, colony formation, and cell invasion and induce apoptosis of the BC cells (all P<0.05), and the effects of miR-142-3p knockout on the BC cells could be reversed by silencing circ_0084927. miR-142-3p could target ERC1. Both ERC1 silencing and circ_0084927 knockout in the BC cells could achieve the tumor-suppressing effect, and this effect could be more remarkable under simultaneous ERC1 silencing and circ_0084927 knockout (all P<0.05).
CONCLUSION: Circ_0084927 can promote the progression of BC by regulating the miR-142-3p/ERC1 axis. AJTR
Copyright © 2021.

Entities:  

Keywords:  ELKS/RAB6-interacting/CAST family member-1; breast cancer; circ_0084927; miR-142-3p

Year:  2021        PMID: 34150003      PMCID: PMC8205726     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  34 in total

1.  Circ_DCAF6 potentiates cell stemness and growth in breast cancer through GLI1-Hedgehog pathway.

Authors:  Guolin Ye; Ruilin Pan; Leiwei Zhu; Dan Zhou
Journal:  Exp Mol Pathol       Date:  2020-07-12       Impact factor: 3.362

Review 2.  Adipocyte biology in breast cancer: From silent bystander to active facilitator.

Authors:  Junjeong Choi; Yoon Jin Cha; Ja Seung Koo
Journal:  Prog Lipid Res       Date:  2017-11-21       Impact factor: 16.195

3.  Circular RNA circ_0067934 functions as an oncogene in breast cancer by targeting Mcl-1.

Authors:  J-M Wang; X-J Li; J Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-11       Impact factor: 3.507

Review 4.  Noncoding RNAs in peritoneal fibrosis: Background, Mechanism, and Therapeutic Approach.

Authors:  Yanhong Guo; Liuwei Wang; Rong Gou; Lin Tang; Peipei Liu
Journal:  Biomed Pharmacother       Date:  2020-07-02       Impact factor: 6.529

5.  circ_0084927 promotes cervical carcinogenesis by sponging miR-1179 that suppresses CDK2, a cell cycle-related gene.

Authors:  Xinhua Qu; Liumei Zhu; Linlin Song; Shaohua Liu
Journal:  Cancer Cell Int       Date:  2020-07-21       Impact factor: 5.722

6.  miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.

Authors:  Xiaoyan Liu; Lei Bi; Qin Wang; Mingxin Wen; Ce Li; Yidan Ren; Qinlian Jiao; Jian-Hua Mao; Chuanxin Wang; Guangwei Wei; Yunshan Wang
Journal:  Oncogene       Date:  2018-03-20       Impact factor: 9.867

7.  A new drug testing platform based on 3D tri-culture in lab-on-a-chip devices.

Authors:  Begum Gokce; Ismail Akcok; Ali Cagir; Devrim Pesen-Okvur
Journal:  Eur J Pharm Sci       Date:  2020-09-12       Impact factor: 4.384

8.  CircRNA UBAP2 facilitates the progression of colorectal cancer by regulating miR-199a/VEGFA pathway.

Authors:  J Dai; Y Zhuang; M Tang; Q Qian; J-P Chen
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-08       Impact factor: 3.507

View more
  2 in total

1.  Circ_0059354 aggravates the progression of papillary thyroid carcinoma by elevating ARFGEF1 through sponging miR-766-3p.

Authors:  Z Li; J Xu; H Guan; J Lai; X Yang; J Ma
Journal:  J Endocrinol Invest       Date:  2021-12-02       Impact factor: 4.256

2.  YY1 as a promoter regulating the circ_0001946/miR-671-5p/EGFR axis to promote chemotherapy resistance in breast cancer cells.

Authors:  Ge Gao; Xiaoyan Li; Jiabeini Zhang; Hong Yu
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.